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A B S T R A C T
Small-ﬁber neuropathy (SFN) patients experience a spectrum of sensory abnormalities, including attenuated
responses to non-noxious temperatures in combination with a decreased density of the small-nerve ﬁbers. Gain-
of-function mutations in the voltage-gated sodium channels SCN9A, SCN10A and SCN11A have been identiﬁed
as an underlying genetic cause in a subpopulation of patients with SFN. Based on clinical-diagnostic tests for
SFN, we have set up a panel of two read-outs reﬂecting SFN in zebraﬁsh, being nerve density and behavioral
responses. Nerve density was studied using a transgenic line in which the sensory neurons are GFP-labelled. For
the behavioral experiments, a temperature-controlled water compartment was developed. This device allowed
quantiﬁcation of the behavioral response to temperature changes. By using these read-outs we demonstrated that
zebraﬁsh embryos transiently overexpressing the pathogenic human SCN9A p.(I228M) or p.(G856D) mutations
both have a signiﬁcantly decreased density of the small-nerve ﬁbers. Additionally, larvae overexpressing the p.
(I228M) mutation displayed a signiﬁcant increase in activity induced by temperature change. As these features
closely resemble the clinical hallmarks of SFN, our data suggest that transient overexpression of mutant human
mRNA provides a model for SFN in zebraﬁsh. This disease model may provide a basis for testing the patho-
genicity of novel genetic variants identiﬁed in SFN patients. Furthermore, this model could be used for studying
SFN pathophysiology in an in vivo model and for testing therapeutic interventions.
1. Introduction
Patients with small-ﬁber neuropathy (SFN) typically complain of
length-dependent neuropathic pain symptoms due to dysfunction and
degeneration of thinly-myelinated Aδ and unmyelinated C-ﬁbers
(Hoeijmakers et al., 2012a; Cazzato and Lauria, 2017). Pain symptoms
can be spontaneous (e.g. burning, deep, paroxysmal pain) and evoked
by innocuous stimuli (e.g. light touch or pressure, warm and cold
water). The diagnosis of SFN is based on the characteristic clinical
picture, and abnormal temperature threshold testing and/or reduced
intraepidermal nerve ﬁber density (IENFD) in a skin biopsy (Cazzato
and Lauria, 2017; Tesfaye et al., 2010; Hoeijmakers et al., 2012a). The
spectrum of etiologies causing SFN has widened and includes gain-of-
function (GOF) mutations in SCN9A, SCN10A and SCN11A, genes en-
coding Nav1.7, Nav1.8, and Nav1.9 alpha subunits of voltage-gated
sodium channels, respectively (Cazzato and Lauria, 2017; Faber et al.,
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2012a; Han et al., 2015; Faber et al., 2012b). Conversely, patients with
homozygous loss-of-function (LOF) mutations in SCN9A present with
congenital indiﬀerence to pain (Cox et al., 2010). Nav1.7, Nav1.8, and
Nav1.9 are abundantly expressed in peripheral sensory neurons and
their axons, where they play a pivotal role in the generation and con-
duction of action potentials (Ho and O'Leary, 2011, Black et al., 2012,
Shields et al., 2012). All three belong to the same family of voltage-
gated sodium channels, consisting of four functional domains with six
transmembrane segments (S1-S6) (Wood and Baker, 2001; Marban
et al., 1998).
Recently, a study in the Netherlands consisting of 921 patients di-
agnosed with SFN has revealed a prevalence of 16.7% of potentially
pathogenic variants in one of these three sodium channel genes (de
Greef et al., 2017). The pathogenicity of genetic variants in these
human sodium channels could be demonstrated by segregation analysis
in large families, when possible, or cell electrophysiological studies,
which are expensive and time-consuming (Waxman et al., 2014). The
characterization of these gene variants could also support the identiﬁ-
cation of new compounds targeting these sodium channels
(Hoeijmakers et al., 2012a). The availability of a simple and rapid so-
dium channel gene-related in vivo model of SFN would provide a
medium-throughput screening tool for testing novel genetic variants
and allow testing the eﬃcacy of available and new candidate analge-
sics. The zebraﬁsh has proven to be an excellent model for neurological
diseases and because of the many similarities between zebraﬁsh and
mammal neuroanatomical organization, it is a good candidate for
modeling SFN (Malafoglia et al., 2013; Becker and Rinkwitz, 2012). The
sensory nervous system in zebraﬁsh consists, like in mammals, of tri-
geminal ganglia, vagal ganglia and dorsal root ganglia (DRG)
(Malafoglia et al., 2013). In addition, zebraﬁsh have an early type of
sensory neurons, Rohon Beard (RB) neurons, which allow the externally
developing embryo to acquire sensory input leading to activation of
escape behavior in case of environmental threats (Reyes et al., 2004;
Malafoglia et al., 2013). Furthermore, the family of voltage-gated so-
dium channels in teleost species share high levels of identity with their
mammalian counterparts and since scn1aa, scn8aa and scn8ab are
broadly expressed in the sensory nervous system, it is likely that sodium
channels play an important role in nociception (Novak et al., 2006).
Knockdown of scn8aa revealed a signiﬁcant eﬀect on inward sodium
current in sensory neurons resulting in a reduced touch response, which
was not observed in scn1aa morphants (Pineda et al., 2005). Zebraﬁsh
have been already used in nociception studies (Taylor et al., 2017;
Prober et al., 2008) taking advantage of their escape behavior in re-
sponse to noxious compounds and elevated water temperatures char-
acterized by increased swimming activity (Gau et al., 2013; Prober
et al., 2008; Curtright et al., 2015). Based on these observations, tem-
perature aversion assays have been developed to test the potential an-
algesic properties of novel compounds (Curtright et al., 2015).
Here, we describe two read-outs for measuring SFN in zebraﬁsh.
These read-outs are based on two clinical hallmarks of SFN, that are the
abnormal response to thermal stimuli (thermal allodynia) and the re-
duced density of sensory neurites. We tested the behavioral read-out by
using a scn8aa LOF line which is expected to have an attenuated re-
sponse to temperature change. To model SFN in the zebraﬁsh, we have
opted for the overexpression of human variants because the functional
zebraﬁsh ortholog of SCN9A has not been identiﬁed and mutations in
this gene are inherited in an autosomal dominant manner. We over-
expressed two human pathogenic SCN9A p.(I228M) and p.(G856D)
GOF mutations that are causative of SFN (Persson et al., 2013;
Hoeijmakers et al., 2012b; Estacion et al., 2011; Faber et al., 2012a).
2. Material & methods
2.1. Zebraﬁsh husbandry
Zebraﬁsh (Danio reiro) were housed and raised in the zebraﬁsh
facility at Maastricht University. Brieﬂy, zebraﬁsh were maintained at a
14 h light and 10 h dark cycle, the water temperature was kept at 27 °C
and adults were fed twice a day (Avdesh et al., 2012). To obtain eggs,
the day before mating males and females, separated by a divider, were
placed in a breeding tank. The next day, after the lights were turned on,
the divider was removed to allow mating. Eggs were collected and
transferred to petri dishes containing E3 medium (Nusslein-Volhard
and Dahm, 2002). The zebraﬁsh line sensory:GFP used in this study was
developed and described by O'Brien and coworkers (O'Brien et al.,
2012). For all imaging studies, to avoid interference of pigmentation
with the ﬂuorescent signal, a sensory:GFP line in a nacre background
was used lacking melanophores (Lister et al., 1999). The scn8aa LOF
nebula zebraﬁsh line tW1752X harbors a premature translation termi-
nation substitution and causes in a homozygous state a LOF of scn8aa
(Wright et al., 2010). Genotyping was performed by KASP by design
(LGC Genomics, Berlin, Germany) with a custom primer targeted to the
following region:
5′CCGCTACAAGTGTTGCGATGTGCCCATCACGGAAGGCTGGGGCA
AGAATT[G/A]GTGGTTTCTCCGAAAGACCTGCTATCTGATTGTGGAGC
ACAACTGGTTTG3′.
2.2. SCN9A mRNA overexpression experiments
Vectors containing wildtype SCN9A and mutant human SCN9A with
GOF mutations (I228M/G856D) were kindly provided by S.G. Waxman
and S.D. Dib-Hajj and were subcloned in a PCS2+ vector for in vitro
mRNA synthesis (Estacion et al., 2011; Hoeijmakers et al., 2012b). To
transcribe full-length mRNA the Ambion mMessage mMachine SP6
transcription kit (Invitrogen, Carlsbad, CA, USA) was used. mRNA
quality was determined by denaturing RNA gel electrophoresis and
quantity was assessed using the Qubit ﬂuorometer 4 (Thermo Fischer
Scientiﬁc, Waltham, MA, USA). A dose of 100 pg of WT or mutant
SCN9A mRNA was injected in the 1–2-cell stage of embryos of sensor-
y:GFP or wild-types (AB). Expression of these constructs was conﬁrmed
at 96 h post-fertilization (hpf) by ampliﬁcation of the 3′ coding se-
quence. RNA extractions were performed according to standard pro-
cedures with TRizol Reagent (Thermo Fischer Scientiﬁc, Waltham, MA,
USA) and for the cDNA transcription, the qScript cDNA Synthesis Kit
was used (Quanta, Beverly, MA, USA).
2.3. Confocal imaging & quantiﬁcation of nerve densities
Prior to imaging with a DMI 4000B microscope (Leica, Wetzlar,
Germany) equipped with a TCS SPE confocal laser scanning module
(Leica, Wetzlar, Germany), manually dechorionated 48 hpf nacre
sensory:GFP embryos expressing human SCN9A (mutant) mRNA, were
anesthetized using tricaine mesylate (Saint Louis, MO, USA) and were
embedded in 2% low melting-point agarose. Image acquisition of the
caudal ﬁn, allowing reproducibility between embryos, was performed
using confocal sections of 1.01 μm. After noise reduction using the LAS
X software (version 3.3), each confocal recording was loaded in ImageJ
software (version 1.50i) and z-projections were converted to 8-bit
images. After manually adjusting the threshold, nerve densities were
quantiﬁed in the caudal ﬁn using the ImageJ Particle Analyzer. For
each image, the mean pixel value was quantiﬁed in ﬁve independent
areas which were subsequently averaged.
2.4. TUNEL staining & quantiﬁcation of Rohon Beard neuron death
Terminal deoxynucleotidyl transferase dUTP nick-end labeling
(TUNEL) staining was combined with whole-mount im-
munocytochemistry as described previously (Svoboda et al., 2001). For
the TUNEL staining, we used the in situ cell death detection kit, TMR
red (Sigma Aldrich, Saint Louis, MO, USA). After the TUNEL staining
nacre sensory:GFP embryos (48 hpf) expressing human SCN9A (mutant)
mRNA were in a dorsal position embedded in 2% low melting-point
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agarose and imaged with a DMI 4000B microscope (Leica, Wetzlar,
Germany) equipped with a TCS SPE confocal laser scanning module
(Leica, Wetzlar, Germany). Image acquisition was performed using
confocal sections of 4.15 μm. After noise reduction using the LAS X
software (version 3.3), each recording was loaded in ImageJ software
(version 1.50i) and z-projections were blinded and the number of
apoptotic RB neurons was counted manually.
2.5. ZebraBox experiments
Temperature sensitivity was assessed with an add-on, developed in-
house, to the ZebraBox system (Viewpoint, Lyon, France and Maastricht
Instruments BV., Maastricht, The Netherlands), consisting of 2 water
reservoirs with water at a high temperature (50.0 °C) and water at a
baseline temperature (28.5 °C) (Fig.2). This setup enabled us to rapidly
increase the water temperature in the water compartment from
28.5 °C ± 0.1 °C to 41.0 °C ± 0.7 °C. The temperature inside the wells
during baseline recording was 27.7 °C and the maximum temperature,
reached at the end of the experiment, was 39.6 °C ± 0.5 °C. At 96 hpf,
zebraﬁsh larvae in a 48-well plate containing 500 μl E3 were placed in
the water compartment. After an adaptation period of 30min in the
dark, at 28.5 °C ± 0.1 °C, the protocol started with a baseline recording
for 10min at 28.5 °C ± 0.1 °C, followed by an increase of the water
temperature. Zebralab software (Viewpoint, Lyon, France) determines
the size of the zebraﬁsh by contrast diﬀerences between zebraﬁsh and
background. The software records the movement of the zebraﬁsh and
determines the activity by the number of pixels that change from one
frame to the next.
2.6. Statistical analysis
GraphPad Prism version 5.02 was used to carry out statistical ana-
lysis, including student t-tests and data were considered signiﬁcant
when the calculated p-value< .05. All data are presented as an
average ± standard error of the mean (SEM).
3. Results
3.1. Read-out panel based on clinical hallmarks of SFN
We used the sensory:GFP zebraﬁsh line to quantify nerve density in
zebraﬁsh embryos. This line allowed visualization of all sensory neu-
rons and enabled us to study the density of sensory neurites in zebra-
ﬁsh. Development of sensory neurites in the zebraﬁsh caudal ﬁn was
monitored during the ﬁrst stages of development (Fig.1). At 48 hpf,
marked by the red frame, a fully developed network of sensory neurites
was formed (Fig. 1). Extension of this network was observed in the
following stage (56 hpf Fig.1). Since retraction of some neurites oc-
curred at later stages (> 48 hpf), all confocal recordings were per-
formed at 48 hpf (Svoboda et al., 2001).
In the second read-out, we aimed at measuring the behavioral re-
sponses to increased water temperatures. Therefore, we developed an
add-on to the commercially-available behavioral tracking device, the
ZebraBox (Fig. 2A,B). This add-on was developed in-house and allowed
to rapidly increase the water temperature in the water compartment
containing a 48-well plate with the zebraﬁsh larvae (Fig. 2B). A more
detailed description of this module is given in the supplemental mate-
rial (Supp. Fig. 1-3). To explore the dynamics of the temperature
change, 6 test runs were performed without larvae (Fig. 2C). Recording
for 10min at baseline temperature revealed minor temperature ﬂuc-
tuations in the water temperature in the compartment
(28.5 °C ± 0.1 °C), however, the temperature inside was for all tests
the same 27.7 °C ± 0.0 °C. Furthermore, these pilot experiments de-
monstrated that we were able to rapidly increase the water temperature
(Fig. 2C). Since the water in the wells is indirectly heated by the water
in the compartment, the temperature inside the wells is lower than the
water temperature in the compartment (Fig. 2C).
In order to test our temperature set-up, we used non-injected con-
trols (Supp. Fig. 4) and a scn8aa LOF model having a defect in the
processing of sensory stimuli caused by a loss of an endogenous zeb-
raﬁsh sodium channel (Low et al., 2010; Wright et al., 2010). Nebula
(scn8aa LOF) mutant zebraﬁsh embryos were selected based on a re-
duced touch response at 48 hpf and divided into two groups; homo-
zygous mutant embryos with a diminished touch response and het-
erozygous mutant and homozygous WT siblings with a normal touch
response (Pineda et al., 2005; Wright et al., 2010). At 96 hpf, these
groups were transferred to the water compartment. After an adaptation
period of 30min and baseline recording at 27.7 °C the larvae were ex-
posed to the rapid temperature change with a maximum of
39.6 °C ± 0.5 °C. As reported before zebraﬁsh larvae responded to the
temperature change with an increase in swimming activity which fur-
ther increased as the temperature rose (Prober et al., 2008) (Fig.3). At
all the elevated temperatures the scn8aamutants displayed signiﬁcantly
decreased activity compared to the control siblings (Fig.3). The diﬀer-
ence in activity between mutants and controls became more prominent
as the temperature increased further (Fig.3). For both groups, the ac-
tivity of larvae peaked during heating but then gradually declined
(Fig.3). All larvae survived the heating protocol and no defects or ab-
normalities were observed afterwards.
3.2. Decreased nerve density in zebraﬁsh expressing mutant SCN9A
Since SCN9A GOF mutations are inherited in an autosomal domi-
nant manner and the zebraﬁsh ortholog of SCN9A is unknown, we
overexpressed in zebraﬁsh either WT human SCN9A or one of two
known human pathogenic mutations in the SCN9A gene, p.(I228M) and
p.(G856D) (Hoeijmakers et al., 2012b; Persson et al., 2013; Estacion
et al., 2011; Faber et al., 2012a). No developmental or morphological
diﬀerences were observed in the ﬁrst 4 days of development in zebra-
ﬁsh embryos expressing (mutant) human SCN9A (Supp. Fig. 5). Ex-
pression of the mutant and SCN9A-WT mRNA was conﬁrmed by RT-
PCR (Supp. Fig. 6).
At 48 hpf, we observed a signiﬁcantly decreased density of sensory
neurites in the caudal ﬁn of zebraﬁsh embryos expressing the p.(I228M)
substitution (20.9% ± 2.8% n=13) and the p.(G856D) substitution
(17.1% ± 4.6% n=7) compared to embryos expressing the Nav1.7
wildtype protein (SCN9A-WT 33,3% ± 1.4 n=12) (Fig.4).
3.3. Increased temperature-related activity in zebraﬁsh expressing mutant
SCN9A protein
Next, we determined the behavioral response of larvae (96 hpf) with
overexpressed human mutant or SCN9A-WT to the temperature change.
As a result of the temperature elevation, both groups, mutant and
SCN9A-WT injected embryos, responded with an increase of their ac-
tivity (Fig. 5A,C). At lower temperatures, no signiﬁcant diﬀerences
were observed in the activity of larvae expressing mutant or SCN9A-
WT. However, at higher temperatures, timepoints 14 and 15min, a
signiﬁcant increase in activity was observed for larvae expressing the p.
(I228M) mutation (Fig. 5A,B). In contrast, for embryos expressing the p.
(G856D) mutation, we observed no signiﬁcant diﬀerent response to the
temperature change at all time points (Fig.5C,D). As observed for the
scn8aa mutants and control siblings, the activity of larvae declined
gradually after reaching a maximum (Fig.5A,C, and Fig.3).
4. Discussion
A recent study performed by our group reported a frequency of
16.7% of potentially pathogenic genetic variants of SCN9A, SCN10A
and SCN11A in an SFN patient cohort (de Greef et al., 2017). This group
contains a high number of variants of unknown clinical signiﬁcance
(VUS). Since in silico prediction algorithms are not infallible, cell
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electrophysiology experiments are time-consuming and co-segregation
analysis cannot provide deﬁnite evidence, there is the need for a model
to provide functional data of these genetic variants (Waxman et al.,
2014; Hoeijmakers, 2014). Furthermore, the model could allow in-
vestigating in vivo the eﬃcacy of available and new candidate analge-
sics at preclinical level.
Here, we report a zebraﬁsh model of SFN, based on overexpression
of human mutant mRNA, providing a platform that may allow testing
the pathogenicity of potentially pathogenic SCN9A variants identiﬁed
in patients.
The read-outs used in our study were based on clinical hallmarks of
SFN, such as thermal allodynia and loss of the intraepidermal nerve
ﬁber density in a skin biopsy (IENFD) (Devigili et al., 2008; Cazzato and
Lauria, 2017; Tesfaye et al., 2010; Hoeijmakers et al., 2012a). We
Fig. 1. Sensory neurite development in the
caudal ﬁn of sensory:GFP embryos at diﬀerent
timepoints.
Sensory neurite development in the caudal ﬁn of
sensory:GFP embryos was followed at several stages
of development (24, 36, 48, and 56 hpf). Indicated
by the red frame is the developmental stage (48 hpf)
that was used to study the eﬀect of the pathogenic p.
(I228M) and p.(G856D) mutations. Images represent
maximal projections of confocal recordings at 20×
magniﬁcation. Scale bar indicates 100 μm.
Fig. 2. Development of a temperature-controlled water compartment.
Panel A. Water reservoir and ﬂow/temperature controller are assembled in two units. The water reservoir unit contains a tank which feeds the water compartment.
The controller unit controls ﬂow rate, temperature and water quality (UV sterilization). Panel B. Because two diﬀerent water reservoirs like depicted in panel A can
feed the water compartment it is possible to rapidly increase or cool down the water temperature of the compartment containing a 48-well plate (Top view and side
view of the water compartment). Temperatures were measured by the temperature sensor inside the water compartment and the temperature sensor in the well.
Panel C. The average temperature change (± SEM) in 6 diﬀerent test runs after 10min of recording at baseline temperature. Blackline indicates the temperature in
the water compartment and the greyline the average of the temperatures measured inside the wells (± SEM).
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included the quantiﬁcation of sensory neurites in a sensory:GFP zebra-
ﬁsh line and the behavioral analysis based on the assay of swimming
activity in response to the increase of water temperature. It was per-
formed developing a temperature-controlled water compartment that
was used as an add-on to the ZebraBox. To assess whether we were able
to reveal diﬀerences in responses to temperature changes, we used the
scn8aa LOF model with a defect in sensory perception that recapitulates
the picture of congenital indiﬀerence to pain of patients harboring LOF
mutations of SCN9A (Cox et al., 2010; Pineda et al., 2005). Our assay
showed a severely diminished reaction to elevated water temperatures
of homozygous mutants. This diﬀerence became more apparent at
higher temperatures, demonstrating that we were able to reveal beha-
vioral diﬀerences in temperature response with our assay. Therefore,
the presence of scn8aa, a key player in sodium inﬂux, in the sensory
nervous system and a LOF of scn8aa that signiﬁcantly aﬀects the re-
sponse to noxious temperatures, suggest that scn8aa could be at least
partially orthologous to SCN9A. Furthermore, these embryos do not
manifest severe motor deﬁcits and retain the capability to swim, de-
monstrated by the initial temperature response observed in our mu-
tants. Supporting these ﬁndings, ﬁctive swimming could be induced in
zebraﬁsh with a LOF of scn8aa (Low et al., 2010).
To model SFN in the zebraﬁsh we overexpressed two pathogenic
human mutations in SCN9A, p.(I228M) and p.(G856D) that are known
to be causative of SFN in patients. Voltage and current clamp studies
revealed that these mutations modulate sensory neuron functioning
(Estacion et al., 2011; Hoeijmakers et al., 2012b; Faber et al., 2012a).
Our experiments revealed that embryos expressing the p.(I228M) or the
p.(G856D) mutation have a signiﬁcantly decreased density of sensory
neurites in the caudal ﬁn. These ﬁndings in zebraﬁsh paralleled the
observations in SFN patients, harboring these mutations, namely de-
creased IENFD and indicates that overexpression of human mutations
generates a zebraﬁsh model of SFN (Estacion et al., 2011, Hoeijmakers
et al., 2012b, Faber et al., 2012a). Further supporting our ﬁndings, the
overexpression of the p.(I288M) variant in DRG neurons was proved to
induce 20% reduction of neurite length after 3 days in culture (Persson
et al., 2013). Conversely, the p.(G856D) mutation did not cause sig-
niﬁcant eﬀects on neurite length in rodent DRG neurons after 3 days in
Fig. 3. Diminished temperature response at 96 hpf for homozygous scn8aa
loss-of-function (LOF) mutants.
At 96 hpf Zebraﬁsh embryos of the nebula (scn8aa LOF) line, placed in a 48 well
plate, were after baseline recording exposed to an elevation of water tem-
perature (dotted line indicates water temperature in the wells plotted on the
right y-axis). This resulted in a signiﬁcantly reduced temperature response for
homozygous scn8aa mutants (grey line) compared to control: scn8aa siblings,
WT and heterozygous mutant (black line). Each data point represents the mean
value (± SEM) of a total of 96 larvae. Signiﬁcance was tested with an unpaired
students t-test (unequal variances). For all data points during the temperature
increase, p-values indicated a high level of signiﬁcance (p < .0001). Activity is
presented as changes in pixels and expressed using Arbitrary Units (AU).
Fig. 4. Decreased nerve density in zebraﬁsh em-
bryos (48 hpf) expressing mutant human SCN9A.
Analysis of maximal projections with the ImageJ
particle analyzer revealed in sensory:GFP embryos
(48 hpf) expressing SCN9A p.(I228M) (Black
squares) or SCN9A p.(G856D) (Black triangles), a
signiﬁcantly decreased nerve density in the tail sec-
tion, when compared to embryos expressing SCN9A-
WT (Black circles). Representative maximal projec-
tions of each group are depicted in the upper panel.
Each data point represents the average GFP% in the
caudal ﬁn per zebraﬁsh embryo and consists of the
analysis of 5 independent regions. The horizontal
line depicts the mean value with SEM. Signiﬁcance
was tested with an unpaired students t-test (unequal
variances). ***Indicates for both comparisons a p-
value of 0.0005. nSCN9A-WT= 12, nSCN9A p.(I228M) =
13, nSCN9A p.(G856D)= 7. Image acquisition, at a
magniﬁcation of 20×, was performed with a con-
focal microscope (DMI 4000B microscope equipped
with a TCS SPE confocal laser scanning module
(Leica, Wetzlar, Germany). Scale bar indicates
100 μm.
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culture, though a signiﬁcant reduction was observed after 30 days in
culture (Rolyan et al., 2016).
An explanation for the diﬀerence between these in vitro studies with
rodent DRG neurons and our results in zebraﬁsh embryos might be
found in the diﬀerent types of sensory neurons. Zebraﬁsh have at this
early developmental stage mainly RB neurons. RB neurons are an early
type of sensory neurons that are transiently present and replaced by
DRG neurons (Svoboda et al., 2001; Malafoglia et al., 2013). This
transition is mediated by the apoptosis of RBs that starts early in de-
velopment; however, retraction of RB neurites is not reported before 48
hpf (Svoboda et al., 2001). Apoptosis in RB neurons is regulated by the
electrical activity of these neurons. A reduction of Na+-current by
pharmacological inhibition (tricaine) or a genetic loss (mao mutants) of
functional sodium channels signiﬁcantly reduced apoptosis and re-
sulted in the presence of RB neurons at later stages of development
(Svoboda et al., 2001). Since increased Na+ inﬂux in DRG neurites
expressing these mutations have been associated with injurious levels of
axonal Ca2+ probably mediated by a reverse operating of the Na+/
Ca2+ exchanger, we hypothesized that increased levels of Na+ current
produced by the mutant channels could contribute to early apoptosis of
RB neurons and thereby a decreased nerve density as observed in our
study (Persson et al., 2016; Persson et al., 2013; Estacion et al., 2015).
Interestingly, at 48 hpf we did not observe any diﬀerences in the
number of apoptotic RB neurons between embryos expressing SCN9A-
WT and the mutant constructs (Supp. Fig. 7). These results indicate that
the decreased nerve densities are not caused by an increase of RB
neuron death at this developmental stage. However, it could be that the
defects arise in earlier developmental stages or that other mechanisms
underlie our observations. Furthermore, it is important to note that a
clear functional ortholog of human SCN9A in teleost species has not
Fig. 5. Increased activity at elevated temperatures for larvae (96 hpf) expressing the SCN9A p.(I228M) mutation.
At 96 hpf, embryos expressing human (mutant) SCN9A were exposed to an elevation of the water temperature (dotted line indicates water temperature in the wells
plotted on the right y-axis). This resulted in a signiﬁcantly increased activity at elevated temperatures for larvae expressing the SCN9A p.(I228M) mutation (Black
line panel A). The maximal activity at the elevated temperatures for the larvae expressing the p.(I228M) mutation is depicted in panel B. Larvae expressing the p.
(G856D) mutation (black line panel C) no signiﬁcant diﬀerences were observed. The maximal activity at the elevated temperatures for larvae expressing the p.
(G856D) mutation is depicted in panel D. Each data point represents the mean value with SEM. (A,B) nSCN9A-WT= 92, nSCN9A p.(I228M) = 96. (C,D) nSCN9A-WT= 69,
nSCN9A p.(G856D)= 68. *Signiﬁcance was tested with an unpaired student's t-test (unequal variances) and was demonstrated for 2 time points, 14 min (p-value .033)
and 15min (p-value .0486) (A). Activity is presented as changes in pixels and expressed in Arbitrary Units (AU).
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been identiﬁed to date (Widmark et al., 2011). As Nav1.7 GOF muta-
tions are inherited in an autosomal dominant manner, we have opted
for the use of an overexpression model (Faber et al., 2012a). Besides
overexpression has the main advantage to test relatively fast the eﬀect
of VUS in comparison to the generation of genetic lines which requires
raising several generations. Therefore, this approach would allow us to
provide rapidly information about the increasing number of VUS.
The second read-out is measured at a later developmental stage (96
hpf), where DRG neurons are gradually taking over the functions of RB
neurons (Reyes et al., 2004). At this stage, we observed an increase in
temperature-related activity for larvae expressing the p.(I228M) mu-
tation, resembling thermal allodynia observed in patients with this
mutation. Remarkably, for the p.(G856D) mutation which is also known
to cause thermal allodynia we did not observe an increase in tem-
perature-related activity. These ﬁndings suggest that at this stage the p.
(I228M) mutant channels had a more pronounced eﬀect on zebraﬁsh
DRG neuron functioning. This is further supported by data from DRG
culture studies, where the p.(I288M) mutation had at earlier stages an
eﬀect on DRG neurite length in comparison to the p.(G856D) mutation
(Persson et al., 2013; Rolyan et al., 2016).
There are some caveats to this study. First, we note that Nav1.7 has
been reported to be expressed in keratinocytes of mammals (Zhao et al.,
2008). The present results do not exclude the possibility that functional
Nav1.7 channels were expressed in zebraﬁsh skin cells, in addition to or
instead of in sensory neurons. Expression in these skin cells could, in
principle, explain the behavioral ﬁndings. Furthermore, expression in
skin could secondarily aﬀect the pattern of innervation, i.e. IENFD.
Even if this is the case, however, it does not detract from our conclusion
that expression of GOF Nav1.7 mutant channels can be detected in
zebraﬁsh in terms of changes that mimic the morphological and clinical
manifestations of SFN. Second, our behavioral read-out demonstrated a
clear increase in activity at elevated temperatures for the p.(I228M)
mutation, but not for p.(G856D). Whether this reﬂects diﬀerent func-
tional proﬁles of the two mutations as documented previously (Estacion
et al., 2011; Hoeijmakers et al., 2012b) or an experimental issue such as
diﬀerent patterns of expression within the zebraﬁsh background, re-
mains to be determined. Irrespective of this, however, we would note
that, for the p.(I228M) mutation, the zebraﬁsh model paralleled the
clinical presentation on both a morphological and behavioral basis.
In conclusion, we have successfully expressed two pathogenic
SCN9A mutations in an in vivo zebraﬁsh model. The functional con-
sequences of these substitutions were tested in a newly developed read-
out panel based on diagnostic criteria of SFN, which revealed a sig-
niﬁcant eﬀect on sensory nerve density for both mutations. In addition
to this morphological result which parallels the clinical proﬁle of SFN,
our observations demonstrated a signiﬁcant increase in activity at ele-
vated temperatures for the p.(I228M) mutation. Taken together, our
results suggest that zebraﬁsh may provide a novel model for assessing
the pathogenicity of VUS substitutions identiﬁed in molecular diag-
nostic tests. Given the many advantages of zebraﬁsh as an experimental
platform, our data suggest a new model for SFN that could be of interest
in studying pathophysiology and for initial screening of potential
therapeutic interventions.
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